NewsWorld’s first blood test for real-time monitoring of cancer
treatment success

7th June 2021by admin0
https://nfusion-tech.com/wp-content/uploads/2021/06/worlds-first-blood-test-for-real-time-monitoring-of-cancertreatment-success_60bf3d3917895.jpeg

Cancer patients who are undergoing targeted therapy
can look forward to a new blood test that could tell their doctors
whether the treatment is working, within one day after the start of
the treatment. This will significantly speed up the evaluation
process and enable doctors to make adjustments to the treatment
plan, if necessary, to improve patients’ chances of
recovery.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2021 New Fusion All Rights Reserved

      Designed by FallingBrick